We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $4.08B
1-Year Est. Return 58.77%
This Fund
S&P 500
This Quarter Est. Return
+8.82%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+536.06%
AUM
$5.94B
AUM Growth
+$2.67B
Cap. Flow
+$2.4B
Cap. Flow %
40.37%
Top 10 Hldgs %
19.09%
Holding
6,103
New
843
Increased
2,477
Reduced
2,101
Closed
546

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$206M
2
MSFT icon
Microsoft
MSFT
+$179M
3
AMZN icon
Amazon
AMZN
+$114M
4
TSLA icon
Tesla
TSLA
+$84M
5
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$59.8M

Top Sells

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$685M
2
DIA icon
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
+$54.5M
3
QQQ icon
Invesco QQQ Trust
QQQ
+$42.1M
4
VOO icon
Vanguard S&P 500 ETF
VOO
+$27.7M
5
IWB icon
iShares Russell 1000 ETF
IWB
+$22.2M

Sector Composition

Rank Sector Weight
1 Technology 20.95%
2 Financials 11.56%
3 Healthcare 11.43%
4 Consumer Discretionary 10.98%
5 Communication Services 8.55%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
VFH icon
3551
Vanguard Financials ETF
VFH
$14B
$31K ﹤0.01%
370
+181
+96% +$14.4K
MGI
3552
DELISTED
MoneyGram International, Inc. New
MGI
$31K ﹤0.01%
4,639
-2,607
-36% -$19.1K
MBII
3553
DELISTED
Marrone Bio Innovations, Inc.
MBII
$31K ﹤0.01%
14,612
-12,914
-47% -$26.8K
ATIP
3554
DELISTED
ATI Physical Therapy, Inc.
ATIP
$31K ﹤0.01%
+62
New +$33.9K
AMNB
3555
DELISTED
American National Bankshares Inc
AMNB
$31K ﹤0.01%
950
-1,446
-60% -$44.6K
ADAP
3556
DELISTED
Adaptimmune Therapeutics
ADAP
$30K ﹤0.01%
5,675
+2,992
+112% +$17.1K
ADV icon
3557
Advantage Solutions
ADV
$399M
$30K ﹤0.01%
+100
New +$26.7K
ASPS icon
3558
Altisource Portfolio Solutions
ASPS
$64.5M
$30K ﹤0.01%
402
+242
+151% +$20.2K
ESQ icon
3559
Esquire Financial Holdings
ESQ
$1.61B
$30K ﹤0.01%
1,290
-2,636
-67% -$60.6K
FROG icon
3560
JFrog
FROG
$11.5B
$30K ﹤0.01%
665
-1,612
-71% -$92.9K
HBIO icon
3561
Harvard Bioscience
HBIO
$28.1M
$30K ﹤0.01%
545
-456
-46% -$22.2K
LARK icon
3562
Landmark Bancorp
LARK
$197M
$30K ﹤0.01%
1,438
-82
-5% -$1.65K
LCNB icon
3563
LCNB Corp
LCNB
$281M
$30K ﹤0.01%
1,757
-391
-18% -$6.57K
MCBS icon
3564
MetroCity Bankshares
MCBS
$1.04B
$30K ﹤0.01%
1,939
-2,350
-55% -$35.4K
OPTT icon
3565
Ocean Power Technologies
OPTT
$55.4M
$30K ﹤0.01%
+8,963
New +$34.5K
OVBC icon
3566
Ohio Valley Banc Corp
OVBC
$211M
$30K ﹤0.01%
1,248
-1,026
-45% -$25.4K
SEED icon
3567
Origin Agritech
SEED
$12.7M
$30K ﹤0.01%
+1,771
New +$36.7K
SIGA icon
3568
SIGA Technologies
SIGA
$206M
$30K ﹤0.01%
4,548
-2,973
-40% -$20.2K
SNDX icon
3569
Syndax Pharmaceuticals
SNDX
$1.77B
$30K ﹤0.01%
1,341
+246
+22% +$5.56K
VSTM icon
3570
Verastem
VSTM
$604M
$30K ﹤0.01%
1,003
-1,521
-60% -$42.6K
VTVT icon
3571
vTv Therapeutics
VTVT
$122M
$30K ﹤0.01%
269
+136
+102% +$13.4K
XLG icon
3572
Invesco S&P 500 Top 50 ETF
XLG
$11B
$30K ﹤0.01%
1,000
-76,440
-99% -$2.23M
PSTX
3573
DELISTED
Poseida Therapeutics, Inc. Common Stock
PSTX
$30K ﹤0.01%
3,100
-1,522
-33% -$14.9K
SLCA
3574
DELISTED
U.S. SILICA HOLDINGS, INC.
SLCA
$30K ﹤0.01%
2,449
-6,468
-73% -$70.4K
VMW
3575
DELISTED
VMware, Inc
VMW
$30K ﹤0.01%
198
-3,635
-95% -$520K
141 142
143
144 145

Similar funds

CA
CSM Advisors Warrendale, Pennsylvania $4.07B AUM 29.62% 1-Year Est. Return
AP
Altarock Partners West Palm Beach, Florida $4.13B AUM 0.04% 1-Year Est. Return
BWA
Brave Warrior Advisors New York $4.04B AUM 1.15% 1-Year Est. Return
JSW
Journey Strategic Wealth Summit, New Jersey $4.03B AUM 33.12% 1-Year Est. Return
GCM
Graham Capital Management Rowayton, Connecticut $4.14B AUM 17.82% 1-Year Est. Return
ZP
Zimmer Partners New York $4.15B AUM 14.2% 1-Year Est. Return
SHCM
Sachem Head Capital Management New York $4.15B AUM 48.05% 1-Year Est. Return
GCM
Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return

Tower Research Capital (TRC)'s Q1 2021 Portfolio in Review

As of Q1 2021, Tower Research Capital (TRC) held 6,103 positions worth $5.94B, up 82% from $3.27B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Tower Research Capital (TRC) deployed $2.4B of net new capital in Q1 2021, opening 843 new positions and adding to 2,477 existing holdings. Its largest new stake was iShares Russell 1000 Growth ETF: 262,344 shares worth $15.9M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 9.8% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $685M trimmed.

  • Tower Research Capital (TRC)'s largest Q1 2021 buy was iShares Russell 1000 Growth ETF: 262,344 shares worth $15.9M.
  • Tower Research Capital (TRC) added most to Apple in Q1 2021, an estimated $206M increase.
  • Tower Research Capital (TRC)'s biggest Q1 2021 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $685M.
  • Tower Research Capital (TRC) fully exited ARK Genomic Revolution ETF in Q1 2021, selling an estimated $7.27M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 19% of its $5.94B portfolio in Q1 2021.
  • Tower Research Capital (TRC) opened 843 new positions and closed 546 in Q1 2021.
  • Tower Research Capital (TRC)'s portfolio value rose 82% quarter-over-quarter to $5.94B.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2021, filed 17 May 2021.